Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/1998

01-04-1998 | SHORT COMMUNICATION

Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes

Authors: S. Spanik, J. Sufliarsky, J. Mardiak, D. Sorkovska, J. Trupl, A. Kunova, E. Kukuckova, V. Rusnakova, A. Demitrovicova, P. Pichna, I. Krupova, K. Kralovicova, F. Mateićka, D. West, V. Krcmery Jr.

Published in: Supportive Care in Cancer | Issue 3/1998

Login to get access
Metadata
Title
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
Authors
S. Spanik
J. Sufliarsky
J. Mardiak
D. Sorkovska
J. Trupl
A. Kunova
E. Kukuckova
V. Rusnakova
A. Demitrovicova
P. Pichna
I. Krupova
K. Kralovicova
F. Mateićka
D. West
V. Krcmery Jr.
Publication date
01-04-1998
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/1998
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200050169

Other articles of this Issue 3/1998

Supportive Care in Cancer 3/1998 Go to the issue

SHORT COMMUNICATION

Epicutaneous breast forms

LETTER TO THE EDITOR

Prevention of Pneumocystis carinii pneumonia with cotrimoxazole 18 mg/kg

SHORT COMMUNICATION

The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support

REVIEW ARTICLE

Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics

Editorial

Introduction

REVIEW ARTICLE

Optimal selection of antiemetics in children receiving cancer chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits